Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization.

Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization. Abstract Text:

Although anticapsular antibodies confer serotype-specific immunity to pneumococci, children increase their ability to clear colonization before these antibodies appear, suggesting involvement of other mechanisms. We previously reported that intranasal immunization of mice with pneumococci confers CD4+ T cell-dependent, antibody- and serotype-independent protection against colonization. Here we show that this immunity, rather than preventing initiation of carriage, accelerates clearance over several days, accompanied by neutrophilic infiltration of the nasopharyngeal mucosa. Adoptive transfer of immune CD4+ T cells was sufficient to confer immunity to naïve RAG1(-/-) mice. A critical role of interleukin (IL)-17A was demonstrated: mice lacking interferon-gamma or IL-4 were protected, but not mice lacking IL-17A receptor or mice with neutrophil depletion. In vitro expression of IL-17A in response to pneumococci was assayed: lymphoid tissue from vaccinated mice expressed significantly more IL-17A than controls, and IL-17A expression from peripheral blood samples from immunized mice predicted protection in vivo. IL-17A was elicited by pneumococcal stimulation of tonsillar cells of children or adult blood but not cord blood. IL-17A increased pneumococcal killing by human neutrophils both in the absence and in the presence of antibodies and complement. We conclude that IL-17A mediates pneumococcal immunity in mice and probably in humans; its elicitation in vitro could help in the development of candidate pneumococcal vaccines.

Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: PLoS pathogens

VOLUME: 4

Page Numbers: e1000159

Journal Abbreviation: PLoS Pathog.

ISSN: 1553-7374

DAY: 19

MONTH: 09

YEAR: 2008

Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 101238921

Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization.

AFFILIATION: Division of Infectious Diseases, Department of Medicine, Children's Hospital, and Harvard Medical School, Boston, Massachusetts, United States of America.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: PLoS Pathog

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization Related Publications

• A robust P-value for treatment effect in meta-analysis with publication bias.
• Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins.
• Association of the pneumococcal pilus with certain capsular serotypes but not with increased virulence.
• Authors' reply.
• Chronic haemolytic anaemia with haemoglobinuria; the Marchiafava-Micheli syndrome.
• Enhanced UV Inactivation of Adenoviruses under Polychromatic UV Lamps.
• Interleukin-17A Mediates Acquired Immunity to Pneumococcal Colonization.
• Recombinant bactericidal/permeability-increasing protein rBPI21 protects against pneumococcal disease.
• Response to rentmeester and garis.
• Some recent advances in cardiology.
• SpxB is a suicide gene of Streptococcus pneumoniae and confers a selective advantage in an in vivo competitive colonization model.
• Streptomycin and Friedländer's bacillus.